All study population (n=104) | CDiC Yaoundé (n=52) | CDiC Bafoussam (n=26) | CDiC Bamenda (n=26) | ||||||||||
PedsQL 3.0 DM | α | T0 | T1 year | p Value | T0 | T1 year | p Value | T0 | T1 year | p Value | T0 | T1 year | p Value |
Diabetes symptoms | 0.71 | 62.2±14.5 | 59.1±15.5 | 0.02 | 62.3±16.3 | 57.7±16.1 | 0.02 | 63.4±11.8 | 55.3±15.9 | 0.08 | 60.9±13.6 | 65.3±11.8 | 0.09 |
Treatment barriers | 0.57 | 60.2±23.2 | 64.2±22.2 | 0.05 | 56.9±23.5 | 60.2±21.8 | 0.30 | 53.6±21.8 | 61.5±19.9 | 0.61 | 73.3±19.2 | 75.0±22.6 | 0.64 |
Treatment adherence | 0.65 | 70.3±19.5 | 68.2±19.8 | 0.25 | 69.1±19.9 | 65.4±20.9 | 0.18 | 64.9±21.7 | 64.9±19.4 | 0.98 | 78.2±13.7 | 77.0±15.3 | 0.77 |
Worries | 0.41 | 45.5±23.3 | 45.1±23.3 | 0.85 | 46.2±24.2 | 46.6±21.8 | 0.87 | 40.7±21.8 | 42.9±25.0 | 0.55 | 49.1±23.3 | 44.2±25.1 | 0.35 |
Communication | 0.54 | 71.6±24.8 | 70.8±28.4 | 0.77 | 71.2±23.9 | 71.2±28.2 | 0.98 | 67.9±28.3 | 67.6±26.6 | 0.95 | 76.3±22.8 | 73.0±31.4 | 0.58 |
Total diabetes score | 0.75 | 61.9±15.5 | 61.5±15.4 | 0.66 | 61.1±14.3 | 60.2±16.8 | 0.60 | 58.1±12.3 | 58.5±14.0 | 0.85 | 67.6±11.4 | 66.9±12.7 | 0.81 |
Data are mean ± SD.
T0, at the inception of the CDiC project; T1 year, 1 year after involvement in the CDiC project.